Champions Oncology (CSBR) Total Liabilities (2011 - 2026)

Champions Oncology has reported Total Liabilities for 16 years, with the latest figure at $22.9 million in Q2 2026.

• On a quarterly basis, Total Liabilities fell 19.78% year-over-year to $22.9 million in Q2 2026; TTM through Apr 2026 was $22.9 million, a 19.78% decrease from a year earlier, with the FY2026 full-year figure at $22.9 million, down 19.78% from the prior year.
• Total Liabilities was $22.9 million for Q2 2026 at Champions Oncology, down from $24.1 million in the prior quarter.
• The five-year high for Total Liabilities was $29.7 million in Q2 2023, with the low at $22.9 million in Q2 2026.
• Average Total Liabilities over 5 years is $26.6 million, with a median of $26.6 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Total Liabilities soared 41.77% in 2022, then slipped 19.78% in 2026.
• Over 5 years, Total Liabilities stood at $27.2 million in 2022, then gained by 3.71% to $28.2 million in 2023, then dropped by 12.91% to $24.6 million in 2024, then gained by 5.59% to $25.9 million in 2025, then dropped by 11.61% to $22.9 million in 2026.
• The last three Total Liabilities figures came in at $22.9 million (Q2 2026), $24.1 million (Q1 2026), and $25.9 million (Q4 2025), per Business Quant data.